CHAIR
:
SPEAKER
(S):
Atsushi Tsukamoto, MSc,PMP, Senior Director, Global Project Management, Daiichi Sankyo Co., Ltd., Japan
Doctoral student at Manchester Business School, originally in the financial sector (London), and now 22 years in Japan working as a trainer and consultant for HRM and HRD issues, particularly intercultural communication and teams www.intecjapan.com/gaz/2012/01/process_risk_and_outsourcing.html
|
Robert Hilke is a consultant/trainer specializing in team diversity. He has lived in Japan for more than 30 years and works with many of Japan's top corporations, including those in the pharmaceutical industry.
|
Description
Growing opportunities for drug development in Asian countries have drawn attention to those countries from the West, and also from other Asian countries. Although some of the traditional cultural styles are considered to be shared within Asia (i.e., Confucian rather than Socratic), other aspects, such as historical background, values and business styles, are very different among Korea, China and Japan. In this session, we will introduce typical pitfalls when working with Asian countries, especially in drug development, together with a framework to understand the commonalities and differences, in order to help the attendees with effective and efficient management of diverse Asian teams.